Patient Care Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Patient Care Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Savient Pharmaceuticals

Officials at Savient Pharmaceuticals announce latest news and research developments

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Savient Pharmaceuticals.

Report 1: Results of a new survey show that two-thirds (65%) of gout patients ranked their typical gout flares - defined as a sudden, intense pain - as either close to, or the worst pain possible and say that the flares last an average of eight days.

Seventy-two percent reported having experienced at least one flare within the last 12 months. The online survey of 321 gout patients was conducted by Harris Interactive on...

• View Other Issues of Patient Care Law Weekly
  
• View Other NewsRx Publications